( 10.1016/j.ejphar.2017.10.049) [DOI] [PubMed] [Google Scholar] 45.Muskiet MHA, Tonneijck L, Smits MM, Van Baar MJB, Kramer MHH, Hoorn EJ, Joles JA, Van Raalte DH
Like their injectable versions, GLP-1 pills can cause gastrointestinal issues
Important safety considerations include a boxed warning for medullary thyroid carcinoma (MTC) risk with most GLP-1 medications, which are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
They are clinical observations being documented and shared among practitioners
Diagnosed with type 2 diabetes in her thirties and then obesity in her fifties, Torres' life was transformed when she was prescribed Ozempic in January 2023
Trulicity (dulaglutide) Approved - A weekly GLP-1 receptor agonist for managing type 2 diabetes that also supports moderate weight loss by regulating appetite and blood sugar